Diagnostic value of ferritin, haptoglobin, α1 antitrypsin, lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation

Respiratory Medicine

Volumn 91, Issue 9, 1997, Pages 517-523

  Alexandrakis, M ^a   Coulocheri, S ^a   Kyriakou, D ^a   Bouros, D ^a   Xirouhaki, N ^a   Siafakas, N ^a   Castanas, E ^a   Eliopoulos, G D ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FERRITIN; HAPTOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EXUDATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL;

EID: 0030882722     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90084-6     Document Type: Article

References (17)

1. Yinnon A, Konijn A, Link G, Moreb J, Hersshko C. Diagnostic value of ferritin in malignant and peritoneal effusions. Cancer 1988; 62: 2564-2568.
2. Light RW. Pleural effusions. Med Clin North Am 1977; 61: 1339-1352.
3. Kockars M, Weber T, Tanner P, Pettersson T. Pleural fluid ferritin concentrations in human disease. J Clin Pathol 1985; 38: 818-824.
4. Esen A, Ozen H, Ayhan A, Tasar C, Remzi F. Serum ferritin: A tumor marker for renal cell carcinoma. J Urol 1991; 145: 1134-1137.
5. Torti S, Kwak E, Miller S et al. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem 1988; 263: 12638.
6. Gail M, Muenz L, Mcintire K, Radovich B. Multiple markers for lung cancer diagnosis: Validation of models for localizated lung cancer. J Natl Cancer Inst 1988; 80: 97-101.
7. Toumbis M, Chondros K, Ferderigos A et al. Clinical evaluation of four tumor markers in malignant and benign pleural effusions. Anticancer Res 1992; 12: 1267-70.
8. Tamura S, Nishigaki T, Moriwaki Y et al. Tumor markers in pleural effusion diagnosis. Cancer 1988; 61: 298-302.
9. Hunder G, McDuffie F, Huston K, Elveback L, Hepper N. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases. J Lab Clin Med 1977; 90: 971-80.
10. Hara N, Abe M, Inuzuka S, Kawarada Y, Shigematsu N. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant and other effusions. Chest 1992; 102: 1060-1064.
11. Kay A, smith A, McGavin C, Tuft S. Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma. J Clin Path 1976; 29: 887-889.
12. Andrews B, Arora N, Shadforth M, Goldeberg S, Davis J. the role of immune complexes in the pathogenesis of pleural effusions. Am Rev Respir Dis 1981; 124: 115-120.
13. Kirkeby K, Prydz H. Lactic dehydrogenase activity in pleural and peritoneal effusions. Scand J Clin Lab Invest 1959; 11: 185-189.
14. Boyer TD, Kahn AM, Reynolds TB. Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels. Arch Intern Med 1978; 138: 1103-1105.
15. 1-antitrypsin. Dig Dis Sci 1990; 35: 1105-9.
16. Elg SA, Carson LF, Fowler JM, Twiggs LB, Moradi MM. Ascites levels of haptoglobin in patients with ovarian cancer. Cancer 1993; 71: 3939-3941.
17. Kuhajda FP, Paintadosi S, Pasternack GR. Haptoglobin- related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. N Engl J Med 1989; 321: 636-641.